International Journal of Experimental Pathology · 2014 · 23 citations · 24 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyNeoplasiaCancer ProgressionChemical CarcinogenesisHepatocellular CarcinomaLiver CancerMalignant NeoplasmsDysplastic ChangesDysplastic LesionsHepatic MalignancyHepatic TumorsHepatocellular Carcinoma PathogenesisMolecular Mechanisms Of Carcinogenesis
Hepatocellular carcinoma (HCC) is a common malignancy with poor clinical outcome, whose histogenesis is the subject of intense debate. Specifically, expression of cytokeratins (CKs) 7 and 19, associated with aggressive biological behaviour, is proposed to reflect a possible progenitor cell origin or tumour dedifferentiation towards a primitive phenotype. This work addresses that problem by studying CKs 7 and 19 expression in N-diethylnitrosamine (DEN)-induced mouse HCCs. ICR mice were divided into six DEN-exposed and six matched control groups. Samples were taken from each group at consecutive time points. Hyperplastic foci (13 lesions) occurred at 29-40 weeks (groups 8, 10 and 12) with diffuse dysplastic areas (19 lesions) and with one hepatocellular adenoma (HCA) (at 29 weeks). HCCs (4 lesions) were observed 40 weeks after the first DEN administration (group 12). CKs 7 and 19 showed identical expression patterns and located to large, mature hepatocytes, isolated or in small clusters. Hyperplastic foci and the single HCA were consistently negative for both markers, while dysplastic areas and HCCs were positive. These results support the hypothesis that CKs 7 and 19 expression in hepatocellular malignancies results from a dedifferentiation process rather than from a possible progenitor cell origin.
24
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Diego F. Calvisi, Sara Ladu, Alexis Gorden et al. · Gastroenterology · 2006 · 728 citations